This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
July 17, 2018 (LBO) – Sri Lanka’s leading telecommunications service provider, Dialog Axiata on Tuesday partnered with VMware to strengthen the country’s enterprise cloud market.
July 13, 2018 (LBO) – Fitch Ratings has removed the Rating Watch Negative on Distilleries Company’s National Long-Term Rating, and has affirmed the rating at ‘AAA(lka)’.
DIAL SPEN SLTL
Jul 09, 2018 (LBO) – SLASSCOM, a representative body that represents growth of the Sri Lankan IT and BPM Industry elected Jeevan Gnanam, chief executive officer/director, Orion City as the organizations Chairman during its Annual General Meeting recently.
Jun 12, 2018 (LBO) – Sri Lanka Economic Summit 2018, organized by the Ceylon Chamber of Commerce to take place on 12th – 14th September at Cinnamon Grand Colombo will be themed “On the Fast Track to a Turnaround”.
The Colombo Stock Exchange (CSE) yesterday said investment flows from the Scandinavian region to Sri Lankan stocks have made a noteworthy improvement in recent years, where inward investments have grown by 39 percent per annum (CAGR) since 2013.
DIAL HHL HNB
May 01, 2018 (LBO) – The merger between Hutchison Telecommunications Lanka (Private) Ltd and Etisalat Lanka (Private) Ltd is likely to relieve some competitive pressures that have undermined Sri Lankan telecom companies’ revenue and EBITDA growth in recent years, Fitch Ratings said..
DIAL 532454 BHRQY BHARTIARTL SLTL
Apr 26, 2018 (LBO) – DOC990 operated by Digital Health (Pvt) Ltd together with Asiri Hospital Holdings on Wednesday announced the expansion of the joint venture partnership with equity investments from Nawaloka Hospitals and Ceylon Hospitals (Durdans).
DIAL NHL ASIR
Sri Lanka’s first and largest Mobile Money and Payment Service, eZ Cash, announced the launch of a new feature that enables customers to top-up their eZ Cash wallets via bank accounts on its cutting edge eZ Cash app. The Bank top up feature supplements the recently introduced QR Scan and pay option which enables smart and convenient money transfer amongst eZ Cash customers or payments across the expansive eZ Cash Merchant network.
A ruling against the Telecommunications Regulatory Commission of Sri Lanka (TRCSL) by the Right to Information Commission under the RTI Act has disclosed that a much sought after spectrum telecommunication frequency had recently been allocated to Mobitel (headed by President Maithripala Sirisena’s brother, Kumarasinghe Sirisena) without open competitive bidding and on ‘an administrative decision.’
Fitch Ratings-Singapore/Colombo- 4 April 2018: Fitch Ratings has affirmed Sri Lanka-based telecom company Dialog Axiata PLC’s National Long-Term Rating at ‘AAA(lka)’. The Outlook is Stable.
DIAL 6888 CALF AXXTF HHL SLTL
From left: Prajeeth Balasubramaniam, Co-founder, BOV Capital, Supun Weerasinghe, Group Chief Executive, Dialog Axiata PLC, Fariq Cader, Vice President – Digital Services, Dialog Axiata PLC, Sameera Wijerathna, CEO, MyDoctor.lk, Mustafa Kassim, CEO, Roar Media and Vipula Dharmapala, Director/CEO – Insureme.lk
Dialog Axiata PLC, Sri Lanka’s premier connectivity provider, has selected new media platform, Roar, insurance broker, InsureMe and integrated healthcare platform MyDoctor.lk as its first phase of investments. The Digital Innovation Fund managed by BOV Capital, marks a definitive shift to foster startups and build further on the business capabilities of digital technology and talent within the country.
Dialog Axiata PLC, Sri Lanka’s premier connectivity provider, in collaboration with Ideamart, hosted Sri Lanka’s first NB-IoT Hackathon (NB-IoT: Narrowband Internet of Things). The first to launch the technology in South Asia in October 2017, NB-IoT is a narrowband radio technology specially designed to enable seamless connectivity amongst devices using Low Power Wide Area (LPWA) technology. Held on the 17th of March, the hackathon consisted of 9 teams tasked with creating NB-IoT solutions using Dialog’s IoT platform or making existing solutions NB-IoT compatible.
Mar 20, 2018 (LBO) – Dialog Broadband Networks, a fully owned subsidiary of Dialog Axiata has entered into a joint venture with St. Anthony’s Property Developers to establish, operate and manage a Data Centre in Sri Lanka.
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to CSE:DIAL / DIALOG AXIATA PLC on message board site Silicon Investor.